I Read The News Today Oh Boy! 7-Mar-2018

Wednesday, Mar 07 2018 by
14

Morning all!

Anpario ( Anpario (LON:ANP) ) – 425p – £98.3m – PER 25.8

Final Results For The 12 Months To End December 2017 – Revenues up 20% to £29.2m (2016: £24.3m), PBT up 27% to £3.4m (2016: £2.7m), Diluted EPS up by 13% to 14.17p (2016: 12.58p). Net Cash £13.6m (2016: £11.1m) and the total Dividend is 18% up on last year, 6.5p. Optimistic about the outlook, potential issues being FX and raw material prices.

I quite like this and I think if the outlook was a little more optimistic I would be more interested. For now I will remain Neutral.

Bioquell ( Bioquell (LON:BQE) ) – 322.5p – £72.5m – PER 28.0

Preliminary Results For The 12 Months To End December 2017 – Revenue up 6% (CC) to £29.2m (2016: £26.5 million), PBT of £3.3 million (2016: £0.1 million), Diluted EPS 10.8p (2016:1.2p) with Cash (and equivalents) at £14.6 million (2016: £8.8 million). 2018 has started in-line.

Doubled in the past 12 months but I don’t see enough here at present to tempt me.

Lookers ( Lookers (LON:LOOK) ) – 93.3p – £370.0m – PER 6.42

Results For The 12 Months To End December 2017 – Revenue up 15% £4,696m (vs £4,088m), Adjusted PBT of £68.4m (vs £64.9m), Adjusted EPS up 1.3% (14.57p) and the Dividend is up 5%. Q1 expected to be in-line with management expectations. Share Buyback also announced, up to £10m.

At present, I am no more keen on buying this today than I was yesterday.

Microgen ( Microgen (LON:MCGN) ) – 500p – £304.4m – PER 27.3

Preliminary Results For The 12 Months To End December 2017 –  Revenue up 46% to £62.6m (2016: £43.0m), 37% excluding the benefit of recent acquisitions. Adjusted Operating Profit up 43% to £13.6m (2016: £9.5), Statutory £11.1m (2016: £8.2m). Adjusted EPS up 39% to 17.1p (2016: 12.3p), Total Dividend for the year will be 6.25p (2016: 5.0 pence), an increase of 25%. Cash is £19.1m (2016: £23.8m). The Chairman states “The Group enters 2018 well positioned with good revenue visibility and an encouraging pipeline of opportunities”.

I am very tempted here and if…

Unlock this article instantly by logging into your account

Don’t have an account? Register for free and we’ll get out your way

Disclaimer:  

As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. The author may own shares in any companies discussed, all opinions are his/her own & are general/impersonal. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.


Do you like this Post?
Yes
No
14 thumbs up
0 thumbs down
Share this post with friends



Anpario plc is a producer and distributor of natural feed additives for animal health, hygiene and nutrition. The Company operates through two segments: UK and Eire, and International. The Company is focused on the manufacture and sale of natural feed additive products to agricultural markets. Its products for the poultry, pig, ruminant and animal feed markets include acidifiers, enzymes, essential oils, pellet binders, antioxidants, mycotoxin binders, mold control products and a range of nutritional premixes and performance enhancers. It offers natural feed additive/flavor called Orego-Stim. It offers its customers a number of omega 3 & 6 supplements for use in feed. Its products in the aquaculture range include growth promoters, immune enhancers and pellet binders for both shrimp and fish. The Company's trading brands are Kiotechagil, Meriden and Optivite, which trade across approximately 70 countries around the world. more »

LSE Price
337p
Change
 
Mkt Cap (£m)
78.6
P/E (fwd)
18.0
Yield (fwd)
2.4

Bioquell Plc is engaged in the design, manufacture and supply of bio-decontamination and containment equipment, related products and services to the pharmaceutical, healthcare, food and defense industries, and testing services to the aerospace, telecoms, defense and other industries. The Company's operating segment is Bio-decontamination (BIO). The Company offers various products, which include Healthcare products, such as Healthcare HP Vapor Services, Healthcare HP Vapor Generators, Healthcare Patient Rooms, Healthcare Pharmacy Workstation, Healthcare Consumables/Accessories and Healthcare Archived Products; Life Science products, such as Life Sciences Aseptic Workstation, Life Sciences HP Vapor Services, Life Sciences Materials Transfer, Life Sciences HP Vapor Generators, Life Sciences Consumables/Accessories and Archived Products, and Defense products, such as Defense CBRN Filtration, Controls, Defense Pre-filtration, and Defense Consumables and Spares. more »

LSE Price
587p
Change
 
Mkt Cap (£m)
n/a
P/E (fwd)
n/a
Yield (fwd)
n/a

Lookers plc operates as a motor retail and aftersales company in the United Kingdom. The Company operates through two business segments: motor distribution and parts distribution. The motor division consists of over 150 franchised dealerships representing over 30 marques from approximately 100 locations. Aftersales represents the servicing, repair and sale of franchised parts to customers' vehicles. Its parts division operates in the independent aftermarket sector of the United Kingdom's motor retail market, where it operates through three operating companies: FPS, Apec Braking and BTN Turbo. FPS is a warehouse distributor of automotive parts. Apec Braking is a provider of dry braking (pads and discs). BTN Turbo is a distributor of turbochargers and supplier of related value added services. Its operations are also carried out across Ireland. It sells approximately 180,000 new and used cars and vans per year. In addition, it has an independent parts distribution business. more »

LSE Price
53p
Change
-0.9%
Mkt Cap (£m)
208.2
P/E (fwd)
4.4
Yield (fwd)
8.1



  Is LON:ANP fundamentally strong or weak? Find out More »


9 Posts on this Thread show/hide all

MrContrarian 7th Mar '18 1 of 9
6

My morning smallcap tweet:

Water Intelligence (LON:WATR), Tyman (LON:TYMN), NATURE (LON:NGR), Mysquare (LON:MYSQ), Volvere (LON:VLE), Palace Capital (LON:PCA), WANdisco (LON:WAND), Mirada (LON:MIRA)

Water Intelligence (WATR) placing at 195 (4% discount) for the acquisition of the Louisville, Kentucky franchise and working cap.
Tyman (TYMN) placing by bookbuild to fund the acquisition of Ashland Hardware.
Nature Group (NGR) in advanced discussions with a preferred bidder having reached agreement on indicative terms and pricing on firesale of O&G division to cut debt. Its lender will wait to end of April 2018.
MySQUAR Limited (MYSQ) The Bell of Doom rings as MYSQ turns to death spiral finance of £2.1m ostensibly to fund a potential acquisition or investment into a company that is developing mobile payment services. If it's for an acquisition why do theyneed the cash now?
Volvere (VLE) FY trading. Rev & preax up substatially due to Impetus Automotive. Shire Foods profit down - "we are investing in Shire so that we have the capability to grow. We expect revenues to increase in 2018 and with that, profitability, although this will depend on our ability to contain the effects of higher raw material and labour costs." NAV 656p (end H1 623p). I hold.
Palace Capital (PCA) increased interest rate hedges to 70% of drawn debt. Will inc av cost of debt from 2.9% to 3.4%.
Wandisco (WAND) Fusion will be sold as a standard component on Alibaba Cloud. WANdisco's first OEM agreement in China significantly expanding addressable market.
Mirada (MIRA) takes a secured one-year loan facility from a shareholder for up to £3m at 15%. FIFTEEN PERCENT! "The Directors are confident that as a result of its pipeline of potential new customer contracts and the expected revenues from its recently won contracts now being implemented, the Company's cashflow position will improve and it will be able to satisfy all debts as they fall due."

| Link | Share
matylda 7th Mar '18 2 of 9
1

My brokers website is down this morning (idealing) and when I called them they couldn't even process an order for me (for VLE) or for anything for that matter.

Anyone else having broker or execution issues this morning or is just idealing?

Think I need to change to one of the bigger players as this is not the only poor (expensive) experience this year.

Considering HL - I assume most are happy with it?

Blog: Briefed Up
| Link | Share | 1 reply
gus 1065 7th Mar '18 3 of 9

Hi matylda.

Thanks as ever for the excellent early morning updates.

I’ve done a couple of trades this morning online via my broker, Charles Stanley. Not the cheapest (£11.50 per trade) but service is good and I like the platform and portfolio reports (including a very good capital gains calculation for my annual tax return). Seems to be working fine at the moment.

With regards to Volvere (LON:VLE) , I’ve bought in the past, prompted by Graham’s analysis and my own review, but found it to be very illiquid. Consequently a small EMS (300 shares quoted, often lower when in demand) and a crazy wide spread of at least 50p/5%. Consequently, I’ve tended to wait for no news or down days and put in market orders at or around mid market and had some success in accumulating a reasonable position. Not sure there’ll be much on offer at a sensible price today.

Gus.

| Link | Share
andrea34l 7th Mar '18 4 of 9
1

Quite a busy day for results!

I think Microgen (LON:MCGN) are exceptionally good value in what is still a frothy market, their Aptitude software is doing extremely well, thus the historical, and more pedestrian, Financial Systems division is less of a drag. The price is quite susceptible to market sentiment so I don't know whether I'll add at the moment... but wishing I'd done so when they were around 400 recently.

Lookers (LON:LOOK) overall look quite tempting, if only for the 4% yield... though the whole sector is on a low PER. The outlook seems reasonable, relative to sector sentiment and particularly with respect to Cambria Automobiles (LON:CAMB) who announced a dull trading statement yesterday, I think Lookers (LON:LOOK) have a broader reach and offering. My favourite in the sector remains, as ever, Marshall Motor Holdings (LON:MMH) which I continue to hold. 

I'm sorry, I don't get the euphoria with Volvere (LON:VLE) - why would one pay up £10 for an NAV of £6.56? That's like going into Currys and seeing a TV for £699 and saying "would you do a deal and sell it to me for £999? I know, I'm looking at this far too simplistically. Different comparison then, slightly more relevant, I have a holding in CLS Holdings (LON:CLI) who have announced, as ever, good results today, with NAV of 286p... and yet the share price is around 243p. One final comparison, more relevant again, is to Draper Esprit (LON:GROW) - they are the closest thing I know to Volvere (LON:VLE) and yet they are only on a 37% premium to NAV compared to a 52% premium that Volvere (LON:VLE) enjoys, and yet they have a much broader (and thus less risky) portfolio, and have recently made a substantial gain on the disposal of one of them. I'm glad Volvere (LON:VLE) is shooting up, for all you holders, but I just don't see the attraction - the performance is also solely down to one, small, company, Impetus... and the only two other holdings they are have are exhibiting a negative performance... with a rather guarded outlook.

| Link | Share
herbie47 7th Mar '18 5 of 9

In reply to post #334593

Hi Matylda, HL is working fine today, I tried to buy some Volvere (LON:VLE) but very illiquid and wide spread, price gone up too much now. HL are generally OK with the odd glitch.

| Link | Share
andrea34l 7th Mar '18 6 of 9
1

BTW Matylda, I'd recommend The Share Centre for execution only trading, the charges are very low, and if you buy 500 shares of them then you get a further discount in buy/sell charges. They are also pretty good at getting a good price on the market for most stocks, I have found. However, for some reason both Volvere (LON:VLE) and Draper Esprit (LON:GROW) are marked as non-dealable (will have to find out why), however a trade in Lookers (LON:LOOK) will go through fine.

| Link | Share
rivaldo 7th Mar '18 7 of 9
2

Andrea341, as regards VLE you need to look a lot deeper.

The quoted NAV is completely understated as regards the true NAV, since it only accounts for each of VLE's investments at their (tiny) cost. Thus the fair value of each investment for what it might fetch on sale has to be extrapolated from its results.

In addition, VLE now holds over £18m of cash, or around 500p per share, plus another 62p per share of freehold property. This alone backs up most of the quoted NAV - which means that all the subsidiaries are valued at almost nothing.

After the June'17 interims, another poster produced a "sum of the parts" valuation as follows which gave an NAV of 1,389p per share, with additional upside as follows:

"1. Shire: My profit assumption for H2 is that it will match last year's H2 of £1.02m. We are now past the anniversary of sterling devaluation, so the negative impact on margins has worked through. The re-pricings they have progressively done through H1, and also the fact that sterling in H2 may actually be better than H2 last year, may make the out-turn better. A full year out-turn PBT of £0.78m, I apply a lowly rating of 5* Post Tax Earnings to derive a value of £3.1m.

2. Impetus: I am hoping for at least £3.7m PBT as already explained. I would value this much more highly, and think a market average P/E of 14 times is prudent given the growth and contractual backing for the earnings. Value £41.4m.

3. Perhaps harshly I give no value to Sira.

4. £2.6m of NTAV given that it is mostly freehold property.

That gives a Gross Value of £47.2m, from which I deduct 20% for Minorities and a further 10% for Bruvva's Bonus for the increase in value created....so net net £31.2m. I would expect year end cash to be at least £22.5m, so my total SOTP valuation of the business is £56.6m (£13.89 a share)."

The above valuation is nicely prudent, but increases to around 1,500p per share if you assume a reasonable 10% growth rate for Impetus, introduce any value at all for Sira Defence etc.

| Link | Share | 1 reply
andrea34l 7th Mar '18 8 of 9

In reply to post #334788

Thanks for the in-depth valuation breakdown, rivaldo - I can't deal in them anyway with my broker.

Andrea

| Link | Share
matylda 7th Mar '18 9 of 9

Thanks all for the comment, most welcome, will have a look at HL and Share Centre - And still considering Volvere (LON:VLE) - Thanks rivaldo too from me for taking the time to provide such a detailed update.

Blog: Briefed Up
| Link | Share

Please subscribe to submit a comment



 Are LON:ANP's fundamentals sound as an investment? Find out More »





Stock Picking Tutorial Centre



Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis